← All Dariohealth CORP filings

Dariohealth CORP 8-K filings

NASDAQ
DRIO
Dariohealth CORP
8-K: DarioHealth Corp. Amends Bylaws, Reduces Stockholder Quorum Requirement
DarioHealth Corp. has amended its bylaws to reduce the quorum requirement for stockholder meetings to 33 1/3% of outstanding shares.
NASDAQ
DRIO
Dariohealth CORP
8-K: DarioHealth Corp. Increases CFO's Base Salary and Bonus Potential
DarioHealth Corp. has increased the annual base salary of its Chief Financial Officer, Zvi Ben-David, to $350,000, with potential for bonuses.
NASDAQ
DRIO
Dariohealth CORP
8-K: DarioHealth Corp. Closes $22.4 Million Preferred Stock Offering
DarioHealth Corp. has completed a private placement of preferred stock, raising approximately $22.4 million in gross proceeds.
NASDAQ
DRIO
Dariohealth CORP
8-K: DarioHealth Corp. Unveils Updated Investor Presentation Highlighting Growth and Synergies Post Twill Acquisition
DarioHealth Corp. released an updated investor presentation detailing its strategic growth plans, including the integration of Twill, aiming for enhanced market position and accelerated profitability.
NASDAQ
DRIO
Dariohealth CORP
8-K: DarioHealth Acquires Twill, Creating Digital Health Powerhouse; Secures $22.4 Million in Financing
DarioHealth Corp. has acquired Twill, Inc., creating a comprehensive digital health platform and securing $22.4 million in a concurrent private placement.